<DOC>
	<DOCNO>NCT00493883</DOCNO>
	<brief_summary>The purpose study provide supervised access treatment TheraSphere速 eligible patient primary metastatic cancer evaluate response treatment , survival toxicity . The study follow objective : - Provide supervised access treatment TheraSphere eligible patient primary metastatic cancer liver . - Evaluate patient experience toxicity associate TheraSphere treatment - Evaluate predispose factor may influence result toxicity</brief_summary>
	<brief_title>Use TheraSphere速 Yttrium-90 Glass Microspheres Primary Metastatic Liver Tumors</brief_title>
	<detailed_description>This study use angiographic administration radioactive TheraSphere速 Yttirum-90 microspheres hepatic artery , treat 50 patient primary secondary cancer involve liver . The study population fail standard therapy , majority cancer liver , good performance status reasonable hepatic function . Outcomes studied response treatment , survival toxicity . 1 . Range patient offer TheraSphere速 2 . Tumor response rate , term size , volume , contrast enhancement PET avidity 3 . Survival time 4 . Determine response relation histology parameter 5 . Ability tolerate repeat treatment 6 . Toxicity , may include radiation induce liver damage , pain , consequence shunt , toxic death .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Age &gt; = 18 . 2 . Cancer visible liver CT , MR , US PET scan . 3 . Primary cancer liver ( hepatocellular carcinoma ) , metastatic cancer involve liver primary limited lung , breast , colon , upper GI , neuroendocrine , melanoma . 4 . Life expectancy great 2 month 5 . Performance status ECOG 2 better ( Ambulatory capable selfcare , unable carry work activity . Up 50 % waking hour . ) 6 . Patients try and/or aware FDA approve therapy condition . 1 . Vascular shunt correct . 2 . Bulky cancer outside liver . Active cancer within liver great volume active cancer outside liver / remainder body . 3 . Pregnancy 4 . Hematologic primary lymphoma , leukemia , myeloma . 5 . Body weight 300 lb . 6 . Evidence portal hypertension , splenomegaly ascites .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Therasphere</keyword>
	<keyword>Yttrium</keyword>
	<keyword>liver</keyword>
	<keyword>cancer</keyword>
	<keyword>radiation</keyword>
</DOC>